During the past decade, Denise Mafra conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Denise Mafra" are "Chronic Kidney Disease" (1 trials), "Gastrointestinal Microbiome" (1 trials), "Inflammation" (1 trials), "Oxidative Stress" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Denise Mafra" in a lesser frequency.

Most popular intervention types in "Denise Mafra" are "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cranberry" (1 trials), "L-sulforaphane 1%" (1 trials), "Placebo" (1 trials) and "Placebo Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Denise Mafra" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Denise Mafra". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Denise Mafra, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Denise Mafra, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".